Overall, these data suggest a potential contribution of BARF1 to EMT in cervical cancer cells, although further studies investigating the DNMT1/E-Cadherin axis and/or the expression profile of other EMT-related molecules are strongly recommended. This evidence concerns the gene DNMT1 and cervical cancer.